7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

78,052.39

+733.04

+0.95%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

Sonoma Pharmaceuticals, Inc. (SNOA)

1.1000 -0.1000 (-8.33%)

At close: October 30 at 4:00:00 PM EDT

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

ACCESS Newswire 2mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

ACCESS Newswire 3mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

ACCESS Newswire 4mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

ACCESS Newswire 7mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

ACCESS Newswire 6mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

ACCESS Newswire 7mo ago

SNOA
-8.33%
CVS

WMT
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

ACCESS Newswire 8mo ago

SNOA
-8.33%
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

ACCESS Newswire 11mo ago

SNOA
-8.33%

Mobilize your Website

View Site in Mobile | Classic

Share by: